title: [Pulmonary differentiation -/ATRA syndrome within the scope of therapy of acute promyelocytic leukemia (APL)].
authors.forename: M
authors.initials: M
authors.lastname: Franke
authors.forename: S
authors.initials: S
authors.lastname: Theurich
authors.forename: F
authors.initials: F
authors.lastname: Beyer
authors.forename: T
authors.initials: T
authors.lastname: Persigehl
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004417:Dyspnea / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D060828:Induction Chemotherapy; D015473:Leukemia, Promyelocytic, Acute / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use; D010996:Pleural Effusion / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000000981:diagnostic imaging; D013866:Thioguanine / Q000009:adverse effects / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014212:Tretinoin / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D003561:Cytarabine; D014212:Tretinoin; D008942:Mitoxantrone; D013866:Thioguanine; D003630:Daunorubicin